Julie L. Sutcliffe, PhD, Chair
University of California Davis, USA
I was born in Rossendale, Lancashire UK and have three older brothers. I am currently a Professor in Biomedical Engineering and Internal Medicine at UC Davis where I am the co-Director of the Center for Molecular and Genomic Imaging and director of the Radiochemistry Research and Training Facility. I began my career in Molecular imaging in 1992 at the Hammersmith Hospital, London, UK and moved to the US in 2002 to take my faculty appointment at UC Davis. In 2005 I was diagnosed with breast cancer, I am a 10 year survivor. I look forward to getting to know you all through WIMIN and look forward to your hearing ideas on how we can do a better job at supporting women in science. More information>
Massachusetts General Hospital/Harvard Medical School, USA
Dr. Anna Moore holds a PhD in Bioorganic Chemistry. She joined the Department of Radiology at Massachusetts General Hospital in 1991 as a postdoctoral fellow and is now a Professor of Radiology and the Director of Molecular Imaging Laboratory at the Athinoula A. Martinos Center for Biomedical Imaging at MGH.
She made major contributions to developing image-guided nucleic acid-based therapies in cancer. Her group was the first to image siRNA delivery to tumors using magnetic resonance and optical imaging. Additional research by her group seeks to develop methods for non-invasive imaging of diabetic pancreas to foster development of more effective therapies to treat this disease. For her contributions to the field of molecular imaging Dr. Moore was elected a Member of the Board of Trustees and the Executive Committee of the World Molecular Imaging Society. She was named a Distinguished Investigator by the Academy of Radiology Research in 2014.
Dr. Moore published her research in high impact journal including Nature Medicine, Cancer Research, Diabetes, Radiology and others. She is a recipient of multiple grant awards from NIH and other agencies. More information>
TECHNA Institute for the Advancement of Technologies for Health
Dr. Jinzi Zheng is a Scientist at the TECHNA Institute for the Advancement of Technologies for Health at the University Health Network (UHN) in Toronto,Ontario, Canada. She also holds an appointment as Assistant Professor at the Institute of Biomaterials and Biomedical Engineering (IBBME) at the University of Toronto. She is a biomedical engineer by training and received her PhD in Medical Biophysics from the University of Toronto in 2009. She completed her post-doctoral training at the French Atomic Energy Commission (CEA) and the French National Institute of Health and Medical Research (INSERM). Jinzi’s research focuses on the development of new technologies for image-guided cancer therapy. She has been the recipient of over 20 awards and is dedicated to translate effective research innovations to improve patient care. In her spare time, she enjoys eating and traveling.
President and CEO of Magnetic Insight
Dr. Christensen received her BS in cell biology and biochemistry from the University California San Diego and a PhD in neuroscience and cell biology from the University of Copenhagen. Her thesis work concentrated in the development of high content cellular imaging technologies to study the functional events caused by teratogenic compounds. Following her graduate degree, has spent the last 18 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc. and Caliper Life Sciences as the global business leader. Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices.
In 2014, she joined Magnetic Insight as President and CEO to commercialize a ground breaking imaging technology called Magnetic Particle Imaging. An ultra-sensitive approach to longitudinal cell tracking, vascular function and functional targeting with direct translation to the clinic.
Outside of the office, Dr Christensen spends her time sailing and skiing with her 2 daughters and husband or kayaking in the Bay Area.
University of California San Francisco
Dr. Jones is an Imaging Science Specialist in the Department of Radiology and Biomedical Imaging at the University of California San Francisco (UCSF). She is also a Principal Investigator of research projects awarded by the National Institute of Health. She earned her B.S. degree in chemistry from the University of San Francisco and Ph.D. in chemistry from the University of California, Davis. Upon completion of her graduate work, she received a postdoctoral fellowship at the University of Oxford in the U.K. and completed her training in 1993.
Dr. Jones has over 12 years of experience in the private sector investigating and developing various molecular constructs for diagnostic imaging and biomedical research. Prior to joining UCSF, Dr. Jones worked as a Senior Scientist/Group Leader at VisEn Medical, researching protease sensing probes for various cancers, rheumatoid arthritis and cardiovascular diseases. Under her leadership, two protease sensing probes, ProSenseTM and MMPSenseTM, have been commercialized and are now available for research use in the imaging community.
At UCSF, Dr. Jones integrated cell biology, protein engineering and synthetic chemistry to develop new reporter systems for in vivo imaging of disease biomarkers. She has successfully produced various probes for preclinical and clinical use in optical and nuclear imaging. More recently, Dr. Jones has taken a new career path focusing on translational breast cancer research. Her current research focuses on the evaluation of normal breast tissues quantified by MR imaging markers as potential independent breast cancer risk factors. She is also the Principal Investigator of a number of research projects incorporating hybrid PET/MR and dedicated breast PET for characterization of breast cancer heterogeneity.
Dr. Jones has vast imaging experience in all modalities spanning from the preclinical to the clinical space. Many researchers are now benefiting from her inventions and probe development work. She published over 30 peer-reviewed articles in top tier scientific journals and 7 patents in diagnostic imaging.
University of Toronto
Naomi Matsuura, PhD, P.Eng., is an Assistant Professor in Medical Imaging with a cross-appointment in Materials Science and Engineering at the University of Toronto. She is the course co-coordinator for the Applied Physics Education Program for the Diagnostic Radiology Residency Program, and a Mentor for the new Masters of Health Science in Translational Research in the Institute of Medical Science at the University of Toronto. As the Director of the Innovation, Translation and Attrition (ITA) Program in Medical Imaging, she leads an initiative to accelerate Medical Imaging innovation in part through establishing interdisciplinary research partnerships between Radiologists, basic scientists and trainees.
Dr. Matsuura leads a research program based on the design of new, translatable contrast agents to guide the personalized treatment of cancer for individual patients. Her group has designed new agents that can be remotely activated using medical imaging sources for cancer imaging and therapy to facilitate the minimally-invasive, image-guided, local and site-specific delivery of cancer therapies to tumours in vivo. Awards and recognitions include the John C. Polanyi Prize in Physiology/Medicine and Physics, an NSERC Discovery Accelerator Award, and the Early Researcher Award from the Ontario Ministry of Research and Innovation.
University of Toronto
Dr. Pinker-Domenig is an Associate Professor of Radiology at the Department of Biomedical Imaging and Image-guided Therapy/Division of Molecular and Gender Imaging at the Medical University of Vienna, Austria and Affiliated Faculty at the Department of Scientific Computing at Florida State University. She is an affiliated researcher at the Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology of the Medical University of Vienna, Vienna, Austria and a senior research associate in the Molecular Imaging and Therapy Service, Department of Radiology, at the Memorial Sloan-Kettering Cancer Center, New York, USA. She serves as an executive board member of the European Society of Breast Imaging (EUSOBI) and as an editorial board member for several journals such as of “insights into Imaging”, “European Radiology”, “Breast Care” and “British Journal of Radiology/ Case Reports“. She is an expert in translational and clinical breast and oncologic gender imaging. Her research interests focus on molecular breast and oncologic gender imaging with high-field/ultra-high-field MRI using multiple advanced MRI parameters and hybrid techniques such as PET/MRI with specific tracers. She has demonstrated that with molecular imaging an improved cancer diagnosis and therapy monitoring of breast, cervix and prostate cancer for precision medicine can be achieved and has successfully translated and integrated several molecular imaging methods and algorithms into clinical practice. She as received recognition in terms of international prizes including the EUSOBI Carla Boetes Young Investigator Award 2014. She has obtained several national and international research grants in molecular imaging in oncologic gender imaging and has published more than 75 peer-reviewed papers in her field of expertise.
University of Cambridge
I am currently a PhD candidate and Breast Radiologist at the University of Cambridge. I was born in London, spent my early childhood in Sri Lanka. I returned to UK as a teenager to complete my schooling and study medicine at Imperial College school of medicine in London. I completed my radiology training and Breast Imaging fellowships at King’s College hospital in London. I spent three months in Vienna and 6 months in NYC on and European School of radiology scholarship and fellowship respectively. During this time I was introduced to the world of molecular imaging. My uncle died in his early 50’s from cancer leaving behind a young family. He died as a result of the complications to treatment. Tumour biology and predicting response to disease and personalized treatment in cancer care is close to my heart. I believe that together we can find personalized, precise, holistic solutions to improve the lives of patients and their families. My PhD Project is on the metabolic heterogeneity of breast cancer. I balance my life in medicine with meditation, yoga and a second life as an artist (a pianist and writer). I find that my life as an artist nourishes and empowers my life in academic medicine.
Anne Menkens, Ph.D., Member
Molecular Imaging Branch
NIH, National Cancer Institute
Laura Pisani, M.D., Member
Assistant Professor, Pediatrics – Medical Genetics
Columbia University Medical Center
Hyunsuk Shim, Ph.D., Member
Department of Radiology and Imaging Sciences
Emory University School of Medicine
Pushpa Tandon, Ph.D., Member
Imaging Guided Intervention Branch
NIH, National Cancer Institute